EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Add-On Treatment with Passiflora incarnata L., herba, during Benzodiazepine Tapering in Patients with Depression and Anxiety: A Real-World Study

Raffaella Zanardi iD, Matteo Carminati, Valentina Fazio iD, Melania Maccario, Greta Verri, Cristina Colombo

Pharmaceuticals · 10.03.2023 · 16 (3) · 426

DOI: 10.3390/ph16030426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 10.03.2023. Verfasst von Raffaella Zanardi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, Vita-Salute San Raffaele University, 20132 Milan, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic and inappropriate benzodiazepine intake represents an important health and social concern worldwide. The aim of our study was to investigate the effectiveness of P. incarnata L., herba, in reducing benzodiazepine misuse in a real-world population of depressed and anxious patients in a long-term treatment with benzodiazepines. We conducted a retrospective naturalistic study on 186 patients undergoing benzodiazepine downtitration, 93 with the addition of a dry extract of P. incarnata L., herba (Group A), and 93 without any add-on treatment (Group B). Regarding the benzodiazepine dosage variation in the two groups, a repeated measure ANOVA showed a significant effect of time (p < 0.001), group (p = 0.018), and time x group interaction (p = 0.011). We found a significantly higher rate, i.e., of 50%, reduction in Group A vs. Group B at 1 month (p < 0.001) and at 3 months (p < 0.001) and complete benzodiazepine discontinuation at 1 month (p = 0.002) and at 3 months (p = 0.016). Our findings suggest the role of P. incarnata as an effective add-on treatment during benzodiazepine tapering. These findings highlight the need for further studies to better investigate the promising properties of P. incarnata in the management of such a relevant clinical and social issue.

Schlagwörter

Stichwörter der Autor:innen

GABAPassiflora incarnataanxietybenzodiazepines discontinuationdepressionpharmacological treatmentreal-world study

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, Vita-Salute San Raffaele University, 20132 Milan, Italy.
  • Department of Clinical Neurosciences, Mood Disorder Unit, IRCCS San Raffaele Institute, 20127 Milan, Italy.

ORCID-Profile: Raffaella Zanardi, Valentina Fazio

Zitieren

APA

Zanardi, R., Carminati, M., Fazio, V., Maccario, M., Verri, G., & Colombo, C. (2023). Add-On Treatment with Passiflora incarnata L., herba, during Benzodiazepine Tapering in Patients with Depression and Anxiety: A Real-World Study. Pharmaceuticals, 16(3), 426. https://doi.org/10.3390/ph16030426

Vancouver

Zanardi R, Carminati M, Fazio V, Maccario M, Verri G, Colombo C. Add-On Treatment with Passiflora incarnata L., herba, during Benzodiazepine Tapering in Patients with Depression and Anxiety: A Real-World Study. Pharmaceuticals. 2023;16(3):426. doi:10.3390/ph16030426

BibTeX
@article{Zanardi2023,
  author = {Zanardi, Raffaella and Carminati, Matteo and Fazio, Valentina and Maccario, Melania and Verri, Greta and Colombo, Cristina},
  title = {Add-On Treatment with Passiflora incarnata L., herba, during Benzodiazepine Tapering in Patients with Depression and Anxiety: A Real-World Study},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {3},
  pages = {426},
  doi = {10.3390/ph16030426}
}
Kostenlos starten →